Clinical study on prevention efficacy of Jianpi Huatan Fang in treating non-alcoholic fatty liver disease in children

Zhongguo Zhongyao Zazhi

Volumn 37, Issue 16, 2012, Pages 2465-2468

  Wu, Fang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Children; Chinese medicine; Jianpi Huatan Fang; Non alcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; JIANPI HUATAN FANG; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFICACY; ECHOGRAPHY; HUMAN; INSULIN RESISTANCE; LIVER; NONALCOHOLIC FATTY LIVER; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; CHILD; DRUGS, CHINESE HERBAL; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE;

EID: 84868617722     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20121625     Document Type: Article

References (9)

1. Gholam P M, Flancbaum L, Machan J T, et al. Nonalcoholic fatty liver disease in severely obese subjects [J]. Am J Gastroenterol, 2007,102(2):399.
2. El-Koofy N M, Anwar G M, El-Raziky M S, et al. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children[J]. Saudi J Gastroenterol, 2012,18(1):44.
3. Gossard A A, Lindor K D. Current therapies for nonalcoholic fatty liver disease[J]. Drugs Today (Barc), 2011,47(12):915.
4. Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images; correlation with histology in diffuse liver disease [J]. Invest Radiol,2000, 35: 319.